Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ILLUMINA, INC. Director's Dealing 2013

Sep 30, 2013

30440_dirs_2013-09-30_d83fe7f0-2c43-40c9-b308-f2d6a2f0ea89.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ILLUMINA INC (ILMN)
CIK: 0001110803
Period of Report: 2013-09-26

Reporting Person: HENRY CHRISTIAN O (Sr VP, General Manager Genomic)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-09-26 Common Stock M 6000.0 $28.45 Acquired 36236 Direct
2013-09-26 Common Stock S 1502.0 $81.0758 Disposed 34734 Direct
2013-09-26 Common Stock S 4498.0 $81.6002 Disposed 30236 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2013-09-26 Non-Qualified Stock Option (right to buy) $28.45 M 6000.0 Disposed 2019-01-28 Common Stock (6000) Direct

Footnotes

F1: The sale was made pursuant to a 10b5-1 plan.

F2: Weighted average sales price representing 1,502 shares sold ranging from $80.38 to $81.37 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.

F3: Weighted average sales price representing 4,498 shares sold ranging from $81.38 to $82.10 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.